Differential specificity of HIV incidence assays in HIV subtypes a and D-infected individuals from Rakai, Uganda

AIDS Research and Human Retroviruses

Volumn 29, Issue 8, 2013, Pages 1146-1150

  Mullis, Caroline E ^a   Munshaw, Supriya ^a   Grabowski, Mary K ^b   Eshleman, Susan H ^a   Serwadda, David ^c,d   Brookmeyer, Ronald ^e   Nalugoda, Fred ^c   Kigozi, Godfrey ^c   Kagaayi, Joseph ^c   Tobian, Aaron A R ^a   Wawer, Maria ^b,c   Gray, Ronald H ^b,c   Quinn, Thomas C ^a,f   Laeyendecker, Oliver ^a,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LYSINE;

ADULT; ARTICLE; CAPTURE ENZYME IMMUNOASSAY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS SUBTYPE A INFECTION; HUMAN IMMUNODEFICIENCY VIRUS SUBTYPE D INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; UGANDA; VIRUS CLASSIFICATION;

ADULT; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; SENSITIVITY AND SPECIFICITY; UGANDA;

EID: 84880543046     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0105     Document Type: Article

References (26)

1. Brookmeyer R. Measuring the HIV/AIDS epidemic. Approaches and challenges. Epidemiol Rev 2010;32(1):26-37.
2. Brookmeyer R and Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995;141(2):166-172.
3. Janssen RS, et al.. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280(1):42-48.
4. Guy R, et al.. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence. A systematic review. Lancet Infect Dis 2009;9(12):747-759.
5. Murphy G and Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type Euro Surveill 2008;13(36):18966.
6. Dobbs T, et al.. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42(6):2623-2628.
7. Masciotra S, et al.. Antibody Avidity-Based Assay for Identifying Recent HIV-1 Infections Based on Genetic Systems TM 1/2 plus O EIA. In 17th Conference on Retroviruses and Opportunistic Infections, Abstract 937. San Francisco, CA, February 16-19, 2010.
8. Barnighausen T, et al.. HIV incidence in rural South Africa. Comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One 2008;3(11). e3640.
9. Karita E, et al.. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007;21(4):403-408.
10. Marinda ET, et al.. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr 2010; 53(4):496-499.
11. Hladik W, et al.. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses 2011;28(1):95-99.
12. Hayashida T, et al.. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 2008;24(3):495-498.
13. Barnighausen T, et al.. HIV incidence estimation using the BED capture enzyme immunoassay. Systematic review and sensitivity analysis. Epidemiology 2010;21(5):685-697.
14. Hallett TB, et al.. Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One 2009;4(5):e5720.
15. Kim AA, et al.. Estimating HIV incidence among adults in Kenya and Uganda. A systematic comparison of multiple methods. PLoS One 2011;6(3):e17535.
16. Laeyendecker O, et al.. Specificity of four laboratory approaches for cross-sectional HIV incidence determination. Analysis of samples from adults with known non-recent HIV infection from five African countries. AIDS Res Human Retroviruses 2012;28(10):1177-1183.
17. Masciotra S, et al.. Antibody Avidity-Based Assay for Identifying Recent HIV-1 Infections Based on Genetic Systems TM - plus O EIA. In 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010.
18. Conroy SA, et al.. Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retroviruses 2010;26(10):1087-1091.
19. Parekh BS, et al.. Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011;27:265-273.
20. Silvina Masciotra TD, et al.. Antibody avidity-based assay for identifying recent HIV-1 infections based on GeneticSystems TM - plus O EIA. In 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010.
21. Hall T. BioEdit. A user-friendly biological sequence alignment editor analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:95-98.
22. Parekh B, et al.. Quantitative detection of increasing HIV type 1 antibodies after seroconversion. A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Human Retroviruses 2002;18(4):295-307.
23. Tamura K, et al.. MEGA5. Molecular Evolutionary Genetic Analysis maximizing likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28:2731-2739.
24. Kiwanuka N, et al.. Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008;197:707-713.
25. Kiwanuka N, et al.. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 2010;54(2):180-184.
26. Baeten J, et al.. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007;195(8):1177-1180.